Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Ligand Pharmaceuticals Incorporated”

124 pharma patents match "Ligand Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 124
Index total 30,257
Page 3 / 6

Quick answer

This filtered view shows 124 pharmaceutical patents matching "Ligand Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

124 results for “Ligand Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7442696

    Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses

    Ligand Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted
  2. US 7439027

    Method for modulating process mediated by farnesoid activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  3. US 7435733

    Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds

    Ligand Pharmaceuticals Incorporated · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted
  4. US 7348359

    Retinoid X receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted
  5. US 7314887

    Thrombopoietin activity modulating compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted
  6. US 7241783

    Thrombopoietin mimetics

    Ligand Pharmaceuticals Incorporated · Granted Jul 10, 2007 · Expires Jul 5, 2027

    granted
  7. US 7214690

    Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2007 · Expires May 3, 2027

    granted
  8. US 7192982

    Modulators of peroxisome proliferator activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted
  9. US 7163946

    5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jan 16, 2007 · Expires Jan 11, 2027

    granted
  10. US 7115728

    Human peroxisome proliferator activated receptor γ

    Ligand Pharmaceuticals Incorporated · Granted Oct 3, 2006 · Expires Sep 28, 2026

    granted
  11. US 7098025

    Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor

    Ligand Pharmaceuticals Incorporated · Granted Aug 29, 2006 · Expires Aug 24, 2026

    granted
  12. US 7084151

    5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Aug 1, 2006 · Expires Jul 27, 2026

    granted
  13. US 7081457

    Cyclothiocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Jul 25, 2006 · Expires Jul 20, 2026

    granted
  14. US 7071205

    5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted
  15. US 7056954

    Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

    Ligand Pharmaceuticals Incorporated · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  16. US 7026484

    Tricyclic androgen receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Apr 11, 2006 · Expires Apr 6, 2026

    expired
  17. US 6992108

    Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

    Ligand Pharmaceuticals Incorporated · Granted Jan 31, 2006 · Expires Jan 26, 2026

    expired
  18. US 6982261

    Cyanopyrroles

    Ligand Pharmaceuticals Incorporated · Granted Jan 3, 2006 · Expires Dec 29, 2025

    expired
  19. US 6964973

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Nov 15, 2005 · Expires Nov 10, 2025

    expired
  20. US 6951942

    Glucocorticoid-selective anti-inflammatory agents

    Ligand Pharmaceuticals Incorporated · Granted Oct 4, 2005 · Expires Sep 29, 2025

    expired
  21. US 6946454

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated · Granted Sep 20, 2005 · Expires Sep 15, 2025

    expired
  22. US 6841568

    Thio-oxindole derivatives

    Ligand Pharmaceuticals Incorporated · Granted Jan 11, 2005 · Expires Jan 6, 2025

    expired
  23. US 6835744

    3,3-substituted indoline derivatives

    Ligand Pharmaceuticals Incorporated · Granted Dec 28, 2004 · Expires Dec 23, 2024

    expired
  24. US 6825222

    Modulators of peroxisome proliferator activated receptors

    Ligand Pharmaceuticals Incorporated · Granted Nov 30, 2004 · Expires Nov 25, 2024

    expired